Like obesity-related NAFLD, lean individuals with NAFLD present decreased levels of adiponectin, an important hormone with insulin-sensitizing and anti-inflammatory effects [32,33]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.